Institutional shares held 931,659
0 calls
0 puts
Total value of holdings $1.49M
$0 calls
$0 puts
Market Cap $33.2M
20,750,100 Shares Out.
Institutional ownership 4.49%
# of Institutions 30


Latest Institutional Activity in PMCB

Top Purchases

Q3 2024
Schonfeld Strategic Advisors LLC Shares Held: 25.9K ($41.4K)
Q3 2024
Dimensional Fund Advisors LP Shares Held: 27.6K ($44.2K)
Q3 2024
Renaissance Technologies LLC Shares Held: 49.7K ($79.5K)
Q3 2024
Maryland Capital Advisors Inc. Shares Held: 35 ($56)
Q3 2024
Jones Financial Companies Lllp Shares Held: 2 ($3.2)

Top Sells

Q3 2024
K2 Principal Fund, L.P. Shares Held: 209K ($335K)
Q3 2024
Susquehanna International Group, LLP Shares Held: 35.2K ($56.4K)
Q3 2024
Ubs Group Ag Shares Held: 8.35K ($13.4K)
Q3 2024
Geode Capital Management, LLC Shares Held: 168K ($269K)
Q3 2024
Tower Research Capital LLC (Trc) Shares Held: 2.86K ($4.58K)

About PMCB

PharmaCyte Biotech, Inc., a biotechnology company, focuses on developing and commercializing cellular therapies for cancer, diabetes, and malignant ascites in the United States. Its cellular therapies are developed based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology used as a platform to treat various types of cancer, including advanced and inoperable pancreatic cancer, as well as diabetes. The company is developing therapies for pancreatic and other solid cancerous tumors; a therapy for Type 1 diabetes and insulin-dependent Type 2 diabetes, which include encapsulated genetically modified insulin-producing cells; and therapies for cancer based on the constituents of the cannabis plant. It has a research agreement with the University of Technology, Sydney to create a version of melligen cells to treat diabetes; and the University of Northern Colorado to develop methods for the identification, separation, and quantification of constituents of cannabis. The company was formerly known as Nuvilex, Inc. and changed its name to PharmaCyte Biotech, Inc. in January 2015. PharmaCyte Biotech, Inc. was incorporated in 1996 and is headquartered in Las Vegas, Nevada.


Insider Transactions at PMCB

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
0 Shares
From 0 Insiders
Sell / Disposition
0 Shares
From 0 Insiders

Track Institutional and Insider Activities on PMCB

Follow PharmaCyte Biotech, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PMCB shares.

Notify only if

Insider Trading

Get notified when an Pharma Cyte Biotech, Inc. insider buys or sells PMCB shares.

Notify only if

News

Receive news related to PharmaCyte Biotech, Inc.

Track Activities on PMCB